LINTUZUMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Approval Year

Substance Class	Protein Created by `admin` on `Sat Dec 16 04:19:02 UTC 2023` Edited by `admin` on `Sat Dec 16 04:19:02 UTC 2023`
Protein Type	MONOCLONAL ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	V00Y10W60W
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

LINTUZUMAB

Official Name

English

SGN-33

Code

English

HUM195

Code

English

HUMA-195-GELONIN

Code

English

HUM-195

Code

English

IMMUNOGLOBULIN G1 ANTI-(HUMAN CD33 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL HUM195 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL HUM195 .KAPPA.-CHAIN, DIMER

Common Name

English

lintuzumab [INN]

Common Name

English

Lintuzumab [WHO-DD]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C20401

Created by admin on Sat Dec 16 04:19:02 UTC 2023 , Edited by admin on Sat Dec 16 04:19:02 UTC 2023

FDA ORPHAN DRUG

235106

Created by admin on Sat Dec 16 04:19:02 UTC 2023 , Edited by admin on Sat Dec 16 04:19:02 UTC 2023

FDA ORPHAN DRUG

158502

Created by admin on Sat Dec 16 04:19:02 UTC 2023 , Edited by admin on Sat Dec 16 04:19:02 UTC 2023

FDA ORPHAN DRUG

238007

Created by admin on Sat Dec 16 04:19:02 UTC 2023 , Edited by admin on Sat Dec 16 04:19:02 UTC 2023

EU-Orphan Drug

EU/3/09/627

Created by admin on Sat Dec 16 04:19:02 UTC 2023 , Edited by admin on Sat Dec 16 04:19:02 UTC 2023

NCI_THESAURUS

C129822

Created by admin on Sat Dec 16 04:19:02 UTC 2023 , Edited by admin on Sat Dec 16 04:19:02 UTC 2023

Code System Code Type Description

CAS

166089-32-3

Created by admin on Sat Dec 16 04:19:02 UTC 2023 , Edited by admin on Sat Dec 16 04:19:02 UTC 2023

PRIMARY

NCI_THESAURUS

C1716

Created by admin on Sat Dec 16 04:19:02 UTC 2023 , Edited by admin on Sat Dec 16 04:19:02 UTC 2023

PRIMARY

ChEMBL

CHEMBL2109150

Created by admin on Sat Dec 16 04:19:02 UTC 2023 , Edited by admin on Sat Dec 16 04:19:02 UTC 2023

PRIMARY

EVMPD

SUB02929MIG

Created by admin on Sat Dec 16 04:19:02 UTC 2023 , Edited by admin on Sat Dec 16 04:19:02 UTC 2023

PRIMARY

WIKIPEDIA

LINTUZUMAB

Created by admin on Sat Dec 16 04:19:02 UTC 2023 , Edited by admin on Sat Dec 16 04:19:02 UTC 2023

PRIMARY

INN

7580

Created by admin on Sat Dec 16 04:19:02 UTC 2023 , Edited by admin on Sat Dec 16 04:19:02 UTC 2023

PRIMARY

FDA UNII

V00Y10W60W

Created by admin on Sat Dec 16 04:19:02 UTC 2023 , Edited by admin on Sat Dec 16 04:19:02 UTC 2023

PRIMARY

DRUG BANK

DB14877

Created by admin on Sat Dec 16 04:19:02 UTC 2023 , Edited by admin on Sat Dec 16 04:19:02 UTC 2023

PRIMARY

From	To
1_22	1_96
1_143	1_199
1_219	3_218
1_225	2_225
1_228	2_228
1_260	1_320
1_366	1_424
2_22	2_96
2_143	2_199
2_219	4_218
2_260	2_320
2_366	2_424
3_23	3_92
3_138	3_198
4_23	4_92
4_138	4_198

Related Record Type Details


					HX0GZ7OLW5

MYELOID CELL SURFACE ANTIGEN CD33

TARGET -> INHIBITOR

Amount:

Related Record Type Details


					V00Y10W60W

ACTIVE MOIETY

Amount:

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
Molecular Formula	CHEMICAL
MOL_WEIGHT:ESTIMATED	CHEMICAL